Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen.
暂无分享,去创建一个
[1] W. McGuire,et al. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. , 1978, The Journal of biological chemistry.
[2] W. McGuire,et al. Progesterone interaction with estrogen and antiestrogen in the rat uterus — receptor effects , 1977, Steroids.
[3] W. McGuire,et al. Estrogen receptor. Unoccupied sites in nuclei of a breast tumor cell line. , 1977, The Journal of biological chemistry.
[4] W. McGuire,et al. Current status of estrogen and progesterone receptors in breast cancer , 1977, Cancer.
[5] W. McGuire,et al. Progesterone and progesterone receptors in experimental breast cancer. , 1977, Cancer research.
[6] B. Katzenellenbogen,et al. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors. , 1977, Cancer research.
[7] V. Jordan,et al. Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat , 1977, Molecular and Cellular Endocrinology.
[8] M. Caron,et al. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. , 1977, Journal of the National Cancer Institute.
[9] T. Allen,et al. REGULATION OF PROGESTERONE RECEPTOR FORMATION BY ESTROGEN ACTION * , 1977, Annals of the New York Academy of Sciences.
[10] D. London,et al. Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course. , 1977, British medical journal.
[11] T. Ruh,et al. Different nuclear binding sites for antiestrogen and estrogen receptor complexes. , 1977, Endocrinology.
[12] S. Legha,et al. Antiestrogens in the treatment of breast cancer. , 1976, Cancer treatment reviews.
[13] M. Lippman,et al. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.
[14] A. Manni,et al. Antiestrogen-induced remissions in stage IV breast cancer. , 1976, Cancer treatment reports.
[15] V. Jordan. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals. , 1976, Cancer treatment reports.
[16] K. Griffiths,et al. Plasma hormones in patients with advanced breast cancer treated with tamoxifen. , 1976, European journal of cancer.
[17] S. Legha,et al. Letter: Antiestrogens in the treatment of cancer. , 1976, Annals of internal medicine.
[18] A. Matsuzawa,et al. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S). , 1976, Cancer research.
[19] W. McGuire,et al. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.
[20] M. Gschwendt. The effect of antiestrogens on egg yolk protein synthesis and estrogen-binding to chromatin in the rooster liver. , 1975, Biochimica et biophysica acta.
[21] B. Katzenellenbogen,et al. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen. , 1975, Endocrinology.
[22] J. Gorski,et al. Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. , 1974, Biochemistry.
[23] T. Ruh,et al. The effect of antiestrogens on the nuclear binding of the estrogen receptor. , 1974, Steroids.
[24] A. Long,et al. A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.
[25] J. H. Clark,et al. Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth. , 1973, Steroids.
[26] G. Flickinger,et al. Column chromatography of steroids on Sephadex LH-20. , 1971, The Journal of clinical endocrinology and metabolism.
[27] L. Terenius. Structure-activity relationships of anti-oestrogens with regard to interaction with 17-beta-oestradiol in the mouse uterus and vagina. , 1971, Acta endocrinologica.
[28] R. Rice,et al. Radioactive labeling of proteins in vitro. , 1971, The Journal of biological chemistry.
[29] George A. Bray,et al. A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter , 1960 .
[30] K. Burton. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. , 1956, The Biochemical journal.
[31] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .
[32] J. H. Clark,et al. Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. , 1977, Endocrinology.
[33] B. Katzenellenbogen,et al. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short- and long-acting derivatives of estriol. , 1976, Endocrinology.
[34] H. Rochefort,et al. Effect of antiestrogens on uterine estradiol receptors. , 1972, Gynecologic investigation.
[35] S. Korenman. Radio-ligand binding assay of specific estrogens using a soluble uterine macromolecule. , 1968, The Journal of clinical endocrinology and metabolism.
[36] Ennis Layne,et al. SPECTROPHOTOMETRIC AND TURBIDIMETRIC METHODS FOR MEASURING PROTEINS , 1957 .